4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-034830
President and CEO sold 18,333 shares at $19.07 ($349,610)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2019-06-03 | Sale | −18,333 | $19.07 | $349,610 | 2,560,971 | I |
| Open-market sales · 18,333 sh · avg $19.07 · $349,610 | |||||||
Loading xslF345X03/doc4.xml…